Trials / Completed
CompletedNCT05415956
"Outwalk MS" - Benefits of Outdoor Walking in Multiple Sclerosis
"Outwalk MS" - Benefits of Outdoor Walking Exercise Therapy on Walking Capacity and Well-being in Multiple Sclerosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Deterioration of walking capacity is a common symptom in persons with multiple sclerosis (pwMS), furthermore having a negative influence on well-being. Studies have nevertheless shown that walking exercise therapy can improve walking capacity in pwMS. This may be particularly potent if occurring outdoors due to the varying stimuli it can provide (different surfaces and terrain etc.), and if the intensity and duration is adequate. Furthermore, outdoor walking is (1) suitable as a group intervention facilitating interaction between pwMS and (2) advantageous due to the health benefits offered through the interaction with nature itself. Both these aspects are also relevant for well-being. Few studies have nevertheless examined the effects of outdoor walking exercise therapy in pwMS. The purpose of the present study is therefore to examine the effects of 7 weeks of moderate-to-high intensity outdoor walking exercise therapy on walking capacity (primary outcome: 6-minute walk test) and well-being in pwMS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Walking exercise therapy | Moderate-to-high intensity walking exercise therapy (7 weeks, 14 session) with progression in duration and intensity. |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2022-07-31
- Completion
- 2022-11-30
- First posted
- 2022-06-13
- Last updated
- 2023-09-01
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05415956. Inclusion in this directory is not an endorsement.